Dermatology for the internist: optimal diagnosis and management of atopic dermatitis
- PMID: 34787024
- PMCID: PMC8604464
- DOI: 10.1080/07853890.2021.2004322
Dermatology for the internist: optimal diagnosis and management of atopic dermatitis
Abstract
Internists are front-line health care providers that commonly provide the first encounter to patients for dermatological conditions, especially atopic dermatitis (AD). Internists need to be comfortable with managing mild-moderate AD in their practices. Criteria and guidelines established in dermatology literature are available to help the general practitioner diagnose and treat AD. AD is a systemic disease associated with multiple cutaneous and extra-cutaneous comorbidities that warrant screening by internists, especially mental health conditions. Environmental factors may play a role in the development or worsening of AD; however, there is currently no strong evidence to guide specific population- or clinic-based interventions for their avoidance. While food allergies are common in AD patients, the role of food allergens as an exacerbating factor for AD is controversial. Before starting any dietary modifications, careful evaluation should be performed by an allergist. If the patient is not well-controlled despite adequate topical therapies or is experiencing severe/worsening disease, early referral to dermatology is warranted to rule out confounding diagnoses and/or escalation to systemic therapies. Finally, it is important to recognise the racial disparities present in AD and address these when formulating treatment plans.Key messages:Confounding dermatoses, either instead of or in addition to AD, should be considered in treatment-refractory AD, and the appropriate workup may be initiated while awaiting dermatology referral.AD patients have multiple cutaneous and extra-cutaneous comorbidities that warrant screening by internists, especially mental health conditions.
Keywords: Atopic dermatitis; autoimmune conditions; bleach baths; cardiovascular; comorbidities; depression; diagnosis; environmental factors; food allergies; infections; internist; mental health; racial disparities; screening; sleep; treatment.
Conflict of interest statement
SN has no conflicts of interest to report. JIS has received honoraria as a consultant, advisory board member or speaker for Abbvie, Afyx, Arena, Asana, BioMX, Bluefin, Bodewell, Boehringer-Ingelheim, Celgene, Dermavant, Dermira, Eli Lilly, Galderma, GlaxoSmithKline, Incyte, Kiniksa, Leo, Luna, Menlo, Novartis, Pfizer, RAPT, Regeneron, Sanofi; institution received grants from Galderma.
Similar articles
-
Current guidelines for the evaluation and management of atopic dermatitis: A comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology guidelines.J Allergy Clin Immunol. 2017 Apr;139(4S):S49-S57. doi: 10.1016/j.jaci.2017.01.009. J Allergy Clin Immunol. 2017. PMID: 28390477 Review.
-
Disease trajectories in childhood atopic dermatitis: an update and practitioner's guide.Br J Dermatol. 2019 Nov;181(5):895-906. doi: 10.1111/bjd.17766. Epub 2019 May 15. Br J Dermatol. 2019. PMID: 30758843 Free PMC article. Review.
-
American Academy of Dermatology Guidelines for Managing Atopic Dermatitis.Adv Exp Med Biol. 2024;1447:217-225. doi: 10.1007/978-3-031-54513-9_18. Adv Exp Med Biol. 2024. PMID: 38724796 Review.
-
Comparison of Dermatology and Allergy Guidelines for Atopic Dermatitis Management.JAMA Dermatol. 2015 Sep;151(9):1009-13. doi: 10.1001/jamadermatol.2015.0250. JAMA Dermatol. 2015. PMID: 25853940 Review.
-
American Academy of Dermatology Guidelines: Awareness of comorbidities associated with atopic dermatitis in adults.J Am Acad Dermatol. 2022 Jun;86(6):1335-1336.e18. doi: 10.1016/j.jaad.2022.01.009. Epub 2022 Jan 24. J Am Acad Dermatol. 2022. PMID: 35085682
Cited by
-
Identification of novel candidate genes and predicted miRNAs in atopic dermatitis patients by bioinformatic methods.Sci Rep. 2022 Dec 21;12(1):22067. doi: 10.1038/s41598-022-26689-8. Sci Rep. 2022. PMID: 36543921 Free PMC article.
-
Machine learning-based prediction models for atopic dermatitis diagnosis and evaluation.Fundam Res. 2023 Mar 21;5(3):1313-1322. doi: 10.1016/j.fmre.2023.02.021. eCollection 2025 May. Fundam Res. 2023. PMID: 40528978 Free PMC article.
-
Assessment of racial and ethnic differences of atopic dermatitis severity and treatment patterns in a diverse outpatient cohort in the United States: a retrospective observational study.Arch Dermatol Res. 2023 Dec;315(10):2829-2832. doi: 10.1007/s00403-023-02696-1. Epub 2023 Aug 17. Arch Dermatol Res. 2023. PMID: 37589796
-
Are behavioral interventions a better choice for atopic dermatitis patients? A meta-analysis of 6 randomized controlled trials.An Bras Dermatol. 2024 Jul-Aug;99(4):503-512. doi: 10.1016/j.abd.2023.09.004. Epub 2024 Mar 27. An Bras Dermatol. 2024. PMID: 38548550 Free PMC article.
-
2023 Consensus Korean Diagnostic Criteria for Atopic Dermatitis.Ann Dermatol. 2025 Feb;37(1):12-21. doi: 10.5021/ad.24.049. Ann Dermatol. 2025. PMID: 39894669 Free PMC article.
References
-
- Chiesa Fuxench ZC, Block JK, Boguniewicz M, et al. . Atopic dermatitis in America study: a cross-sectional study examining the prevalence and disease burden of atopic dermatitis in the US adult population. J Invest Dermatol. 2019;139(3):583–590. - PubMed
-
- Hua T, Silverberg JI.. Atopic dermatitis in US adults: epidemiology, association with marital status, and atopy. Ann Allergy Asthma Immunol. 2018;121(5):622–624. - PubMed
-
- Sacotte R, Silverberg JI.. Epidemiology of adult atopic dermatitis. Clin Dermatol. 2018;36(5):595–605. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical